HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators.

Abstract
The efficacy of low-energy T wave shocks for induction of ventricular fibrillation (VF) was evaluated in 33 patients undergoing implantable cardioverter defibrillator (ICD) implantation (33 sessions) or predischarge ICD testing (20 sessions). To induce VF, the ventricle was paced for eight cycles at a 400-ms cycle length (S1-S1), and the T wave was scanned with a monophasic shock (S2) delivered via the defibrillating lead system. Of 294 attempts, the T wave shocks induced VF in 65%, nonsustained ventricular tachycardia in 10%, and less than five ventricular beats in 25%. As compared with the failed T shocks, the mean energy of successful T wave shocks was higher and the S1-S2 coupling interval was shorter. When the S2 timing was examined in relation to the T wave peak, the VF induction efficacy was 37% for shocks delivered more than 70 ms before the T wave peak, 82% for shocks delivered 30-70 ms before the T wave peak, and 50% for shocks delivered less than 30 ms before or just after the T wave peak (P < .001). Thus, in patients undergoing ICD implantation or ICD conversion testing, the use of low-energy T wave shocks is an effective and safe method to provoke VF.
AuthorsA K Bhandari, N Isber, M Estioko, T Ziccardi, D S Cannom, Y Park, R D Lerman, C Prejean, G W Sun
JournalJournal of electrocardiology (J Electrocardiol) Vol. 31 Issue 1 Pg. 31-7 (Jan 1998) ISSN: 0022-0736 [Print] United States
PMID9533375 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Defibrillators, Implantable
  • Electric Countershock (methods)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Ventricular Fibrillation (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: